PDEX Key Statistics, Chart & Performance
The current stock price of PDEX is 41.68 USD. In the past month the price increased by 5.61%. In the past year, price increased by 0.47%.
PDEX Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to PDEX. When comparing the yearly performance of all stocks, PDEX is one of the better performing stocks in the market, outperforming 84.23% of all stocks.
PDEX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to PDEX. PDEX scores excellent on profitability, but there are some minor concerns on its financial health.
PDEX Financial Highlights
Over the last trailing twelve months PDEX reported a non-GAAP Earnings per Share(EPS) of 3.19. The EPS increased by 107.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.94% | ||
| ROA | 17.41% | ||
| ROE | 26.96% | ||
| Debt/Equity | 0.21 |
PDEX Forecast & Estimates
7 analysts have analysed PDEX and the average price target is 57.12 USD. This implies a price increase of 37.04% is expected in the next year compared to the current price of 41.68.
For the next year, analysts expect an EPS growth of -4.43% and a revenue growth 4.48% for PDEX
PDEX Ownership
About PDEX
Company Profile
Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The company is headquartered in Irvine, California and currently employs 181 full-time employees. The firm has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. The company also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. The company has an approximately 25,000 square foot industrial building in Tustin, California (the Franklin Property).
Company Info
PRO-DEX INC
2361 McGaw Ave
Irvine CALIFORNIA 92614 US
CEO: Richard L. Van Kirk
Employees: 181
Phone: 19497693200
PRO-DEX INC / PDEX FAQ
Can you describe the business of PRO-DEX INC?
Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The company is headquartered in Irvine, California and currently employs 181 full-time employees. The firm has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. The company also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. The company has an approximately 25,000 square foot industrial building in Tustin, California (the Franklin Property).
What is the current price of PDEX stock?
The current stock price of PDEX is 41.68 USD. The price increased by 2.03% in the last trading session.
What is the dividend status of PRO-DEX INC?
PDEX does not pay a dividend.
What is the ChartMill technical and fundamental rating of PDEX stock?
PDEX has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What sector and industry does PRO-DEX INC belong to?
PRO-DEX INC (PDEX) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the market capitalization of PDEX stock?
PRO-DEX INC (PDEX) has a market capitalization of 135.88M USD. This makes PDEX a Micro Cap stock.